[HTML][HTML] PRMT5 function and targeting in cancer
H Kim, AR Ze'ev - Cell stress, 2020 - ncbi.nlm.nih.gov
Protein methyl transferases play critical roles in numerous regulatory pathways that underlie
cancer development, progression and therapy-response. Here we discuss the function of …
cancer development, progression and therapy-response. Here we discuss the function of …
Metacaspases
L Tsiatsiani, F Van Breusegem, P Gallois… - Cell Death & …, 2011 - nature.com
Metacaspases are cysteine-dependent proteases found in protozoa, fungi and plants and
are distantly related to metazoan caspases. Although metacaspases share structural …
are distantly related to metazoan caspases. Although metacaspases share structural …
[HTML][HTML] A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors
X Cui, X Zhang, M Liu, C Zhao, N Zhang, Y Ren, C Su… - Genomics, 2020 - Elsevier
Although emerging cell-or animal-based evidence supports the relationship between SND1
and cancers, no pan-cancer analysis is available. We thus first explored the potential …
and cancers, no pan-cancer analysis is available. We thus first explored the potential …
The Tudor SND1 protein is an m6A RNA reader essential for replication of Kaposi's sarcoma-associated herpesvirus
N 6-methyladenosine (m6A) is the most abundant internal RNA modification of cellular
mRNAs. m6A is recognised by YTH domain-containing proteins, which selectively bind to …
mRNAs. m6A is recognised by YTH domain-containing proteins, which selectively bind to …
Human miR‐221/222 in physiological and atherosclerotic vascular remodeling
DA Chistiakov, IA Sobenin, AN Orekhov… - BioMed research …, 2015 - Wiley Online Library
A cluster of miR‐221/222 is a key player in vascular biology through exhibiting its effects on
vascular smooth muscle cells (VSMCs) and endothelial cells (ECs). These miRNAs …
vascular smooth muscle cells (VSMCs) and endothelial cells (ECs). These miRNAs …
Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells
G Khalili-Tanha, M Moghbeli - Cellular & Molecular Biology Letters, 2021 - Springer
Resistance against conventional chemotherapeutic agents is one of the main reasons for
tumor relapse and poor clinical outcomes in cancer patients. Various mechanisms are …
tumor relapse and poor clinical outcomes in cancer patients. Various mechanisms are …
Readers of histone methylarginine marks
S Gayatri, MT Bedford - Biochimica et Biophysica Acta (BBA)-Gene …, 2014 - Elsevier
Arginine methylation is a common posttranslational modification (PTM) that alters roughly
0.5% of all arginine residues in the cells. There are three types of arginine methylation …
0.5% of all arginine residues in the cells. There are three types of arginine methylation …
Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma
BK Yoo, PK Santhekadur, R Gredler, D Chen… - Hepatology, 2011 - journals.lww.com
There is virtually no effective treatment for advanced hepatocellular carcinoma (HCC) and
novel targets need to be identified to develop effective treatment. We recently documented …
novel targets need to be identified to develop effective treatment. We recently documented …
Tudor staphylococcal nuclease is an evolutionarily conserved component of the programmed cell death degradome
JF Sundström, A Vaculova, AP Smertenko… - Nature cell …, 2009 - nature.com
Programmed cell death (PCD) is executed by proteases, which cleave diverse proteins thus
modulating their biochemical and cellular functions. Proteases of the caspase family and …
modulating their biochemical and cellular functions. Proteases of the caspase family and …
Tudor staphylococcal nuclease links formation of stress granules and processing bodies with mRNA catabolism in Arabidopsis
Abstract Tudor Staphylococcal Nuclease (TSN or Tudor-SN; also known as SND1) is an
evolutionarily conserved protein involved in the transcriptional and posttranscriptional …
evolutionarily conserved protein involved in the transcriptional and posttranscriptional …